HM
HealthCor Management Portfolio holdings
AUM
$109M
This Quarter Return
+10.33%
1 Year Return
+11.46%
3 Year Return
+50.01%
5 Year Return
+144.68%
10 Year Return
–
AUM
$1.66B
AUM Growth
+$1.66B
(+0.28%)
Cap. Flow
-$153M
Cap. Flow
% of AUM
-9.21%
Top 10 Holdings %
Top 10 Hldgs %
48.8%
Holding
74
New
24
Increased
13
Reduced
11
Closed
20
Top Buys
| 1 |
Zimmer Biomet
ZBH
|
$76M |
| 2 |
AGN
Allergan plc
AGN
|
$54M |
| 3 |
AGN
ALLERGAN INC
AGN
|
$49.3M |
| 4 |
AbbVie
ABBV
|
$47M |
| 5 |
BEAM
BEAM INC COM STK (DE)
BEAM
|
$46.9M |
Top Sells
| 1 |
Biogen
BIIB
|
$64.6M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
$62M |
| 3 |
MDRX
Veradigm Inc. Common Stock
MDRX
|
$58M |
| 4 |
MDCO
Medicines Co
MDCO
|
$51.5M |
| 5 |
Celldex Therapeutics
CLDX
|
$50.5M |
Sector Composition
| 1 | Healthcare | 71.03% |
| 2 | Financials | 7.57% |
| 3 | Consumer Staples | 7.31% |
| 4 | Materials | 2.05% |
| 5 | Real Estate | 0.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
McKesson
MCK
$85.4B
| $22.2M | 1.19% | +173,218 | New | +$22.2M |
|
27
Zoetis
ZTS
$69.3B
| $21M | 1.13% | +675,000 | New | +$21M |
|
28
Estee Lauder
EL
$33B
| $21M | 1.12% | +300,000 | New | +$21M |
|
29
Dynavax Technologies
DVAX
$1.19B
| $20.9M | 1.12% | 17,600,000 | – | – |
|
|
ACOR
30
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $18.8M | 1.01% | 550,000 +148,200 | +37% | +$5.07M |
|
|
CYNO
31
DELISTED
Cynosure, Inc. Class A
CYNO
| $16.5M | 0.89% | 725,000 +125,000 | +21% | +$2.85M |
|
32
PTC Therapeutics
PTCT
$3.92B
| $15.7M | 0.84% | +732,200 | New | +$15.7M |
|
|
CLVS
33
DELISTED
Clovis Oncology, Inc.
CLVS
| $15.6M | 0.83% | 256,021 +131,021 | +105% | +$7.97M |
|
34
Elevance Health
ELV
$71.8B
| $14.6M | 0.78% | +175,000 | New | +$14.6M |
|
|
WBMD
35
DELISTED
WebMD Health Corp.
WBMD
| $12.8M | 0.69% | +450,000 | New | +$12.8M |
|
36
Novavax
NVAX
$1.21B
| $11M | 0.59% | +3,498,000 | New | +$11M |
|
|
NUVA
37
DELISTED
NuVasive, Inc.
NUVA
| $10.4M | 0.56% | 425,000 -1,025,000 | -71% | -$25.1M |
|
|
RGLS
38
DELISTED
Regulus Therapeutics
RGLS
| $9.19M | 0.49% | +975,000 | New | +$9.19M |
|
39
CorVel
CRVL
$4.57B
| $8.06M | 0.43% | 218,000 -538,922 | -71% | -$19.9M |
|
40
Coca-Cola Europacific Partners
CCEP
$40.4B
| $8.04M | 0.43% | +200,000 | New | +$8.04M |
|
41
Exelixis
EXEL
$10.1B
| $7.31M | 0.39% | +1,255,350 | New | +$7.31M |
|
42
Pfizer
PFE
$141B
| $6.77M | 0.36% | +235,500 | New | +$6.77M |
|
|
CMRX
43
DELISTED
Chimerix, Inc.
CMRX
| $6.59M | 0.35% | 300,000 -183,072 | -38% | -$4.02M |
|
44
Eli Lilly
LLY
$657B
| $6.14M | 0.33% | +121,929 | New | +$6.14M |
|
|
ACGN
45
DELISTED
Aceragen, Inc. Common Stock
ACGN
| $5.69M | 0.31% | +3,270,000 | New | +$5.69M |
|
|
ITMN
46
DELISTED
INTERMUNE INC
ITMN
| $4.17M | 0.22% | 271,100 -2,828,900 | -91% | -$43.5M |
|
47
Thermo Fisher Scientific
TMO
$186B
| $3.77M | 0.2% | +40,926 | New | +$3.77M |
|
48
Mettler-Toledo International
MTD
$26.8B
| $3M | 0.16% | +12,514 | New | +$3M |
|
49
Cooper Companies
COO
$13.4B
| $2.85M | 0.15% | 21,969 +14,369 | +189% | +$1.86M |
|
50
Healthpeak Properties
DOC
$12.5B
| $2.76M | 0.15% | 67,300 +22,700 | +51% | +$930K |
|